• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值、全身炎症指数及衍生中性粒细胞与淋巴细胞比值的动态变化独立预测危重症 COVID-19 患者有创机械通气需求和死亡情况。

Dynamic Changes of the Neutrophil-to-Lymphocyte Ratio, Systemic Inflammation Index, and Derived Neutrophil-to-Lymphocyte Ratio Independently Predict Invasive Mechanical Ventilation Need and Death in Critically Ill COVID-19 Patients.

作者信息

Moisa Emanuel, Corneci Dan, Negoita Silvius, Filimon Cristina Raluca, Serbu Andreea, Negutu Mihai Ionut, Grintescu Ioana Marina

机构信息

Department of Anaesthesia and Intensive Care Medicine, Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Clinic of Anaesthesia and Intensive Care Medicine, Elias Emergency University Hospital, 011461 Bucharest, Romania.

出版信息

Biomedicines. 2021 Nov 10;9(11):1656. doi: 10.3390/biomedicines9111656.

DOI:10.3390/biomedicines9111656
PMID:34829883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8615772/
Abstract

BACKGROUND

Hematological indices can predict disease severity, progression, and death in patients with coronavirus disease-19 (COVID-19).

OBJECTIVES

To study the predictive value of the dynamic changes (first 48 h after ICU admission) of the following ratios: neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), monocyte-to-lymphocyte (MLR), systemic inflammation index (SII), and derived neutrophil-to-lymphocyte (dNLR) for invasive mechanical ventilation (IMV) need and death in critically ill COVID-19 patients.

METHODS

Observational, retrospective, and multicentric analysis on 272 patients with severe or critical COVID-19 from two tertiary centers. Hematological indices were adjusted for confounders through multivariate analysis using Cox regression.

RESULTS

Patients comprised 186 males and 86 females with no difference across groups ( > 0.05). ΔNLR > 2 had the best independent predictive value for IMV need (HR = 5.05 (95% CI, 3.06-8.33, < 0.0001)), followed by ΔSII > 340 (HR = 3.56, 95% CI 2.21-5.74, < 0.0001) and ΔdNLR > 1 (HR = 2.61, 95% CI 1.7-4.01, < 0.0001). Death was also best predicted by an NLR > 11 (HR = 2.25, 95% CI: 1.31-3.86, = 0.003) followed by dNLR > 6.93 (HR = 1.89, 95% CI: 1.2-2.98, = 0.005) and SII > 3700 (HR = 1.68, 95% CI: 1.13-2.49, = 0.01).

CONCLUSIONS

Dynamic changes of NLR, SII, and dNLR independently predict IMV need and death in critically ill COVID-19 patients.

摘要

背景

血液学指标可预测冠状病毒病19(COVID-19)患者的疾病严重程度、进展及死亡情况。

目的

研究以下比值(入住重症监护病房后最初48小时内)的动态变化:中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、单核细胞与淋巴细胞比值(MLR)、全身炎症指数(SII)以及衍生中性粒细胞与淋巴细胞比值(dNLR)对重症COVID-19患者有创机械通气(IMV)需求及死亡的预测价值。

方法

对来自两个三级中心的272例重症或危重症COVID-19患者进行观察性、回顾性多中心分析。通过使用Cox回归的多变量分析对血液学指标的混杂因素进行校正。

结果

患者包括186例男性和86例女性,各组间无差异(>0.05)。ΔNLR>2对IMV需求具有最佳的独立预测价值(HR = 5.05(95%CI,3.06 - 8.33,<0.0001)),其次是ΔSII>340(HR = 3.56,95%CI 2.21 - 5.74,<0.0001)和ΔdNLR>1(HR = 2.61,95%CI 1.7 - 4.01,<0.0001)。NLR>11对死亡的预测也最佳(HR = 2.25,95%CI:1.31 - 3.86,=0.003),其次是dNLR>6.93(HR = 1.89,95%CI:1.2 - 2.98,=0.005)和SII>3700(HR = 1.68,95%CI:1.13 - 2.49,=0.01)。

结论

NLR、SII和dNLR的动态变化可独立预测重症COVID-19患者的IMV需求及死亡情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/6cf694704c09/biomedicines-09-01656-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/766752b0cc7e/biomedicines-09-01656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/3a369d86dc4f/biomedicines-09-01656-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/6eda3dbcc0c0/biomedicines-09-01656-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/6cf694704c09/biomedicines-09-01656-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/766752b0cc7e/biomedicines-09-01656-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/3a369d86dc4f/biomedicines-09-01656-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/6eda3dbcc0c0/biomedicines-09-01656-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd64/8615772/6cf694704c09/biomedicines-09-01656-g004.jpg

相似文献

1
Dynamic Changes of the Neutrophil-to-Lymphocyte Ratio, Systemic Inflammation Index, and Derived Neutrophil-to-Lymphocyte Ratio Independently Predict Invasive Mechanical Ventilation Need and Death in Critically Ill COVID-19 Patients.中性粒细胞与淋巴细胞比值、全身炎症指数及衍生中性粒细胞与淋巴细胞比值的动态变化独立预测危重症 COVID-19 患者有创机械通气需求和死亡情况。
Biomedicines. 2021 Nov 10;9(11):1656. doi: 10.3390/biomedicines9111656.
2
Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients.白细胞及全身炎症指标(中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、单核细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值、中性粒细胞与淋巴细胞比值乘积、急性炎症严重指数、全身炎症反应指数-I和全身炎症反应指数)在入院时的作用可预测非老年和老年COVID-19患者的院内死亡率。
Front Med (Lausanne). 2022 Aug 18;9:916453. doi: 10.3389/fmed.2022.916453. eCollection 2022.
3
The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients.入院时的全身炎症指数可预测 COVID-19 患者的住院死亡率。
Molecules. 2020 Dec 4;25(23):5725. doi: 10.3390/molecules25235725.
4
Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.系统免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值可预测纳武利尤单抗治疗转移性非小细胞肺癌患者的临床结局。
J Clin Lab Anal. 2019 Oct;33(8):e22964. doi: 10.1002/jcla.22964. Epub 2019 Jul 8.
5
Hematological ratios in coronavirus disease 2019 patients with and without invasive mechanical ventilation.2019冠状病毒病患者有创机械通气与无创机械通气情况下的血液学比率
J Investig Med. 2023 Apr;71(4):321-328. doi: 10.1177/10815589221149189. Epub 2023 Jan 20.
6
Predictive Role of Biomarkers in COVID-19 Mortality.生物标志物在新冠病毒疾病死亡中的预测作用。
Cureus. 2023 Jan 24;15(1):e34173. doi: 10.7759/cureus.34173. eCollection 2023 Jan.
7
The correlation of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with disease severity in recurrent aphthous stomatitis.复发性阿弗他溃疡患者的全身免疫炎症指数、中性粒细胞与淋巴细胞比值、衍生中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与疾病严重程度的相关性。
J Cosmet Dermatol. 2022 Oct;21(10):4858-4863. doi: 10.1111/jocd.14838. Epub 2022 Feb 18.
8
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population.COVID-19的预后预测因素:墨西哥人群中急性全身炎症指标分析
Front Med (Lausanne). 2022 Oct 21;9:1000147. doi: 10.3389/fmed.2022.1000147. eCollection 2022.
9
COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.血液系统恶性肿瘤患者全血细胞计数衍生的炎症生物标志物
Georgian Med News. 2020 May(302):39-44.
10
Comparative analysis of neutrophil to lymphocyte ratio and derived neutrophil to lymphocyte ratio with respect to outcomes of in-hospital coronavirus disease 2019 patients: A retrospective study.关于2019年冠状病毒病住院患者预后的中性粒细胞与淋巴细胞比值及衍生中性粒细胞与淋巴细胞比值的比较分析:一项回顾性研究。
Front Med (Lausanne). 2022 Jul 22;9:951556. doi: 10.3389/fmed.2022.951556. eCollection 2022.

引用本文的文献

1
Predictive model for coronavirus disease 2019 severity based on blood biomarkers: a retrospective study.基于血液生物标志物的2019冠状病毒病严重程度预测模型:一项回顾性研究。
Front Med (Lausanne). 2025 Aug 8;12:1597082. doi: 10.3389/fmed.2025.1597082. eCollection 2025.
2
The association of neutrophil-to-lymphocyte ratio with post-chemotherapy pulmonary infection in lung cancer patients.中性粒细胞与淋巴细胞比值与肺癌患者化疗后肺部感染的相关性
Front Med (Lausanne). 2025 Apr 9;12:1559702. doi: 10.3389/fmed.2025.1559702. eCollection 2025.
3
Pronounced effects of the sepsis-obesity paradox in elderly and male individuals without septic shock and the role of immune-inflammatory status: an analysis of MIMIC-IV data.

本文引用的文献

1
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.REGEN-COV 抗体组合在门诊 COVID-19 患者中的应用及结果。
N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29.
2
Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients.新冠病毒肺炎患者院内高死亡率相关的中性粒细胞与淋巴细胞比值临界值的验证
Int J Gen Med. 2021 Sep 1;14:5111-5117. doi: 10.2147/IJGM.S326666. eCollection 2021.
3
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.
脓毒症-肥胖悖论在无感染性休克的老年和男性个体中的显著影响及免疫炎症状态的作用:一项对多中心重症医学信息数据库-IV数据的分析
BMC Infect Dis. 2025 Apr 17;25(1):545. doi: 10.1186/s12879-025-10938-y.
4
Evaluation of Novel Combined CBC-Derived Systemic Inflammatory Ratios and Their Dynamic Changes as ICU Mortality Predictors, a Retrospective Cohort.评估新型全血细胞计数衍生的全身炎症比值及其动态变化作为重症监护病房死亡率预测指标:一项回顾性队列研究
Health Sci Rep. 2025 Mar 5;8(3):e70441. doi: 10.1002/hsr2.70441. eCollection 2025 Mar.
5
Immune Cell-Based versus Albumin-Based Ratios as Outcome Predictors in Critically Ill COVID-19 Patients.基于免疫细胞与基于白蛋白的比率作为危重症COVID-19患者预后预测指标的比较
J Inflamm Res. 2025 Jan 3;18:73-90. doi: 10.2147/JIR.S488972. eCollection 2025.
6
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as mortality predictors in acute Aluminum phosphide (grain pills) poisoning: clinical insights and risk assessment.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值作为急性磷化铝(丸剂)中毒死亡率预测指标:临床见解与风险评估
Toxicol Res (Camb). 2024 Dec 13;13(6):tfae212. doi: 10.1093/toxres/tfae212. eCollection 2024 Dec.
7
Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital.研究实验室炎症标志物和基于血常规的炎症标志物对 COVID-19 患者疾病严重程度和预后的预测价值:在一家大学附属医院传染病医院进行的研究。
Ann Med. 2024 Dec;56(1):2415401. doi: 10.1080/07853890.2024.2415401. Epub 2024 Oct 24.
8
Meta-analysis of the systemic immune-inflammatory index and in-hospital mortality of COVID-19 patients.新型冠状病毒肺炎患者全身免疫炎症指数与院内死亡率的Meta分析
Heliyon. 2023 Dec 8;10(1):e23441. doi: 10.1016/j.heliyon.2023.e23441. eCollection 2024 Jan 15.
9
During the Omicron Pandemic Wave, the Severe Systemic Inflammatory Status of COVID-19 Indicated a Higher Risk of In-Hospital Mortality and Mediated the Clinical Efficacy of Corticosteroids.在奥密克戎大流行期间,新冠病毒病的严重全身炎症状态表明住院死亡率较高,并介导了皮质类固醇的临床疗效。
Infect Drug Resist. 2023 Nov 30;16:7377-7387. doi: 10.2147/IDR.S432679. eCollection 2023.
10
Assessment of the Diaphragm Thickness Decrease in Critically Ill COVID-19 Patients: Could Computed Tomography Be of Aid Regarding Diaphragm Muscle Mass?危重症 COVID-19 患者膈肌厚度减少的评估:计算机断层扫描对评估膈肌肌肉质量有帮助吗?
Cureus. 2023 Oct 17;15(10):e47195. doi: 10.7759/cureus.47195. eCollection 2023 Oct.
COVID-19 疫苗在预防≥65 岁成年人住院方面的有效性 - COVID-NET,13 个州,2021 年 2 月至 4 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093. doi: 10.15585/mmwr.mm7032e3.
4
The Clinical Implication of Dynamic Hematological Parameters in COVID-19: A Retrospective Study in Chongqing, China.COVID-19中动态血液学参数的临床意义:中国重庆的一项回顾性研究
Int J Gen Med. 2021 Jul 30;14:4073-4080. doi: 10.2147/IJGM.S321292. eCollection 2021.
5
Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis.巴基斯坦 SARS-COV-2 感染患者的血液学和生化学参数作为诊断和预后标志物:一项回顾性比较分析。
Hematology. 2021 Dec;26(1):529-542. doi: 10.1080/16078454.2021.1950898.
6
Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19.基于血常规的比值作为 COVID-19 患者 ICU 收治的预后标志物。
BMC Emerg Med. 2021 Jul 27;21(1):89. doi: 10.1186/s12873-021-00480-w.
7
Biomarkers Predictive of Extubation and Survival of COVID-19 Patients.预测新型冠状病毒肺炎患者拔管及生存的生物标志物
Cureus. 2021 Jun 5;13(6):e15462. doi: 10.7759/cureus.15462. eCollection 2021 Jun.
8
Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019.2019年重症冠状病毒病患者外周血中性粒细胞的动力学
Clin Transl Immunology. 2021 Apr 29;10(4):e1271. doi: 10.1002/cti2.1271. eCollection 2021.
9
Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2.早期使用托珠单抗与感染严重急性呼吸综合征冠状病毒2的危重症患者生存率提高相关。
Crit Care Explor. 2021 Mar 29;3(4):e0395. doi: 10.1097/CCE.0000000000000395. eCollection 2021 Apr.
10
Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis.新冠病毒疾病确诊患者的肥胖与死亡率:一项系统综述和荟萃分析
Front Med (Lausanne). 2021 Feb 5;8:620044. doi: 10.3389/fmed.2021.620044. eCollection 2021.